Help - Search - Members - Calendar
Full Version: Salvia Divinorium, treatment for ADHD/low libido?
Mind and Muscle Forums > Chemically Correct > Neuroscience, Health & Longevity
Pages: 1, 2
Frangible
Now I'm sure you're thinking... "wtf? CITE!". Well, here you go:

QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...st_uids=2572689

1: J Pharmacol Exp Ther. 1989 Nov;251(2):422-7. Links
D2/D1 ratio in the medial preoptic area affects copulation of male rats.

* Hull EM,
* Warner RK,
* Bazzett TJ,
* Eaton RC,
* Thompson JT,
* Scaletta LL.

Department of Psychology, State University of New York at Buffalo, Amherst.

The D1/D2 dopamine agonist apomorphine, microinjected into the medial preoptic area (MPOA), facilitates male rat sexual behavior and the D1/D2 antagonist cis-flupenthixol in the MPOA impairs it. The present study investigated the roles of D1 and D2 receptors in the regulation of copulation by microinjecting drugs selective for these receptors into the MPOA. The D2 agonist LY-163502 delayed the onset and slowed the rate of copulation and also reduced the number of vaginal intromissions required to trigger ejaculation (reduced ejaculatory threshold). The D1 agonist SKF-82526 had no effect, either alone or together with LY-163502. The D1 antagonist SCH-23390 delayed the onset of copulation and decreased ejaculatory threshold, as had the D2 agonist. A low dose of the D2 agonist alone and together with the D1 antagonist delayed the onset of copulation and reduced ejaculatory threshold; the combination of drugs was more effective than LY-163502 alone. Only the combination of drugs slowed the rate of copulation and delayed the resumption of copulation after an ejaculation. Thus, increasing the D2/D1 ratio in the MPOA, by selective stimulation of D2 and/or antagonism of D1 receptors, delays the onset of copulation and reduces ejaculatory threshold, possibly by altering autonomic control of penile reflexes.

PMID: 2572689 [PubMed - indexed for MEDLINE]


QUOTE
1: Dev Med Child Neurol. 2004 Mar;46(3):179-83.Click here to read Links
ADHD: increased dopamine receptor availability linked to attention deficit and low neonatal cerebral blood flow.

* Lou HC,
* Rosa P,
* Pryds O,
* Karrebaek H,
* Lunding J,
* Cumming P,
* Gjedde A.

Centre of Functionally Integrative Neuroscience and PET Centre, Aarhus University Hospital, Aarhus, Denmark. hclou@inet.uni2.dk

Attention-deficit-hyperactivity disorder (ADHD), while largely thought to be a genetic disorder, has environmental factors that appear to contribute significantly to the aetiopathogenesis of the disorder. One such factor is pretern birth with vulnerable cerebrovascular homeostasis. We hypothesised that cerebral ischaemia at birth could contribute to persistent deficient dopaminergic neurotransmission, which is thought to be the pathophysiological basis of the disorder. We examined dopamine D(2/3) receptor binding with positron emission tomography (PET) using [11C] raclopride as a tracer, and continuous reaction times (RT) with a computerized test of variables (TOVA) in six adolescents (12-14 years of age, one female) who had been examined with cerebral blood flow (CBF) measurements at preterm birth and had a subsequent history of attention deficit. We found that high dopamine receptor availability ('empty receptors') was linked with increased RT and RT variability, supporting the concept of a dopaminergic role in symptomatology. High dopamine receptor availability was predicted by low neonatal CBF, supporting the hypothesis of cerebral ischaemia as a contributing factor in infants susceptible to ADHD.

PMID: 14995087 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...l=pubmed_docsum

1: J Neurosci Res. 2006 Aug 1;84(2):450-9.Click here to read Links
Repeated administration of the selective kappa-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens.

* Fuentealba JA,
* Gysling K,
* Magendzo K,
* Andres ME.

Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Catholic University of Chile, Santiago, Chile.

Reinforcing properties of drugs of abuse are reduced by the coadministration of kappa opioid receptor (KOR) agonists. (Salvia = kappa opioid receptor agonist, guys) This effect is related to the inhibition of dopamine (DA) release in the nucleus accumbens (NAc) produced by the acute administration of KOR agonists. The present study was undertaken to investigate the in vivo effect of the repeated administration of KOR agonist on extracellular DA levels in the NAc. Rats were injected once daily with the selective KOR agonist U-69593 (0.16-0.32 mg/kg) or vehicle for 4 days. Microdialysis studies assessing extracellular concentration of DA in the NAc under basal and K(+)-stimulatory conditions were conducted 1 day later. The microdialysis studies revealed that preexposure to U-69593 had no effect on basal extracellular DA levels but significantly augmented the amount of extracellular DA induced by high K(+) compared with vehicle pretreated rats. The D2 receptor agonist quinpirole perfused through the dialysis probe in the NAc, although it produced a significant decrease on basal and K(+)-stimulated DA levels in control rats, it did not decrease significantly either basal or K(+)-stimulated DA levels in U-69593 preexposed rats. Preexposure to U-69593 did not alter the expression of tyrosine hydroxylase or dopamine transporter in the ventral tegmental area. These results show that repeated administration of U-696593 increases the amount of extracellular DA induced by high K in the NAc, an effect that may be related to decreased D2 autoreceptor function. It is suggested that repeated activation of KOR changes the response status of dopaminergic neurons in the NAc.

PMID: 16676328 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...t_uids=11169785

1: Synapse. 2001 Mar 15;39(4):343-50.Click here to read Links
Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.

* Acri JB,
* Thompson AC,
* Shippenberg T.

Integrative Neuroscience Unit, Behavioral Neuroscience Branch, NIDA-IRP, 6001 Executive Blvd. Room 4123, MSC 9551, Bethesda, MD 20892-9551, USA. jacri@nih.gov

The repeated administration of selective kappa-opioid receptor agonists prevents the locomotor activation produced by acute cocaine administration and the development of cocaine-induced behavioral sensitization. Previous studies have shown that dopamine (DA) D2 autoreceptors modulate the synthesis and release of DA in the striatum. Evidence that kappa agonist treatment downregulates DA D2 receptors in this same brain region has recently been obtained. Accordingly, the present studies were undertaken to examine the influence of repeated kappa-opioid receptor agonist administration on pre- and postsynaptic DA D2 receptor function in the dorsal striatum using pre- and postsynaptic receptor-selective doses of quinpirole. Rats were injected once daily with the selective kappa-opioid receptor agonist U69593 (0.16-0.32 mg/kg s.c.) or vehicle for 3 days. Microdialysis studies assessing basal and quinpirole-evoked (0.05 mg/kg s.c.) DA levels were conducted 2 days later. Basal and quinpirole-stimulated locomotor activity were assessed in a parallel group of animals. The no-net flux method of quantitative microdialysis revealed no effect of U69593 on basal DA dynamics, in that extracellular DA concentration and extraction fraction did not differ in control and U69593-treated animals. Acute administration of quinpirole significantly decreased striatal DA levels in control animals, but in animals treated with U69593, the inhibitory effects of quinpirole were significantly reduced. Quinpirole produced a dose-related increase in locomotor activity in control animals, and this effect was significantly attenuated in U69593-treated animals. These data reveal that prior repeated administration of a selective kappa-opioid receptor agonist attenuates quinpirole-induced alterations in DA neurotransmission and locomotor activity. These results suggest that both pre- and postsynaptic striatal DA D2 receptors may be downregulated following repeated kappa-opioid receptor agonist administration. Synapse 39:343-350, 2001. Published 2001 Wiley-Liss, Inc.

PMID: 11169785 [PubMed - indexed for MEDLINE]


I think Ram Dass would approve.

Caveats:

1. Rat studies
2. Kappa agonist other than salvia

Cue "Lipan Conjuring" by Tool.

If my little theory is at all valid, you gotta wonder what other drugs the South American shaman had that could have therapeutic applications today.
Frangible
So I started wondering what would naturally raise kappa opioid ligand levels, not that I would want to stop anyone from being a psychonaut!

QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...l=pubmed_docsum

1: Pharmacol Biochem Behav. 2004 Jan;77(1):49-57.Click here to read Links
Sensitivity to the effects of a kappa opioid in rats with free access to exercise wheels: differential effects across behavioral measures.

* Smith MA,
* McClean JM,
* Bryant PA.

Department of Psychology, Davidson College, Davidson, NC 28035, USA. masmith@davidson.edu

It is well established that chronic exercise decreases sensitivity to mu opioid agonists; however, it is less clear what effects it has on kappa opioids. The purpose of the present study was to examine sensitivity to the effects of the selective, kappa opioid spiradoline in rats with free access to exercise wheels. Rats were obtained at weaning and randomly assigned to either standard polycarbonate cages (sedentary) or modified cages equipped with exercise wheels (exercise). After approximately 7 weeks under these conditions, sensitivity to the effects of spiradoline on tests of antinociception, locomotor activity, conditioned place preference, and diuresis were examined in both groups of rats. Sedentary rats were more sensitive than exercising rats to the antinociceptive effects of spiradoline, and this effect was observed at both low and high nociceptive intensities. In contrast, exercising rats were more sensitive than sedentary rats to the diuretic effects of spiradoline, and slightly more sensitive to spiradoline's effects in the conditioned place preference procedure. No differences in sensitivity were observed to the effects of spiradoline on locomotor activity. Sensitivity to the antinociceptive effects of spiradoline nonsignificantly increased in exercising rats that were reassigned to sedentary housing conditions, and changes in spiradoline sensitivity were correlated with exercise output in individual subjects. Collectively, these data suggest that exercise alters sensitivity to the behavioral effects of kappa opioids, but that the direction and magnitude of this effect depends on the behavioral measure examined.

PMID: 14724041 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...l=pubmed_docsum

1: Pharmacol Biochem Behav. 2000 Jun;66(2):343-6.Click here to read Links
Long-term voluntary access to running wheels decreases kappa-opioid antinociception.

* D'Anci KE,
* Gerstein AV,
* Kanarek RB.

Department of Psychology, Tufts University, Medford, MA 02155, USA.

Previous research has demonstrated that voluntary exercise is associated with a reduction in mu-opioid-induced antinociception. To determine if the effects of voluntary exercise on opioid-induced antinociception were limited to drugs that affect the mu opioid receptor or were more general, the analgesic effects of the kappa opioid agonist U50,488H were compared in active and sedentary rats. Eight adult male Long-Evans rats were housed in standard hanging cages and eight in cages with attached running wheels for 20 days prior to antinociceptive testing. Pain thresholds were determined using a tail-flick procedure, and antinociception was expressed as percent maximal possible effect (%MPE). In the first study, U50,488H was administered in a cumulative dosing procedure (5.0, 10.0, 20.0 mg/kg). Tail-flick latencies were measured immediately prior to and 30 min following each injection. In the second study, the time course of U50,488H effects was examined in animals from the first experiment. Tail-flick latencies were measured immediately prior to and 30, 60, and 90 min following 10.0 mg/kg U50,488H. In the first study, U50,488H produced significant antinociception in both groups of rats. However, antinociceptive responses were significantly reduced for rats given access to running wheels relative to inactive rats. In the second study, antinociceptive responses to U50,488H continued for 90 min. Again, antinociceptive responses were lower for rats given access to running wheels relative to inactive rats. These results indicate that long-term voluntary exercise decreases the antinociceptive properties of the kappa agonist U50,488H, as well as the mu agonist morphine.

PMID: 10880688 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...st_uids=9264068

1: Pharmacol Biochem Behav. 1997 Sep;58(1):43-9.Click here to read Links
Dietary modulation of mu and kappa opioid receptor-mediated analgesia.

* Kanarek RB,
* Przypek J,
* D'Anci KE,
* Marks-Kaufman R.

Department of Psychology, Tufts University, Medford, MA 02155, USA.

Research has demonstrated that intake of palatable carbohydrates and fats enhanced morphine-induced analgesia (MIA) in Sprague-Dawley rats. To determine if the effects of palatable foods on nociceptive responses would generalize to other strains of animals and other opioid agonists, the present experiments investigated whether intake of palatable foods would: a) alter MIA in Long-Evans rats, and cool.gif alter analgesia produced by drugs acting at kappa opioid receptors. In experiment 1, adult male Long-Evans rats were fed Purina chow alone or chow and either a 32% sucrose solution, a 0.15% saccharin solution, or hydrogenated vegetable fat. Using a tail-flick apparatus, nociceptive responses, measured as percent maximal possible effect (%MPE), were examined after morphine administration [0.0, 1.0, 3.0, and 6.0 mg/kg subcutaneously (SC)]. %MPEs varied directly as a function of dose and were significantly greater for rats fed chow and either sucrose or fat than for rats fed chow alone or chow and saccharin. Experiment 2 compared the analgesic effect of the kappa opioid receptor agonist U50,488H (0, 5.0, 10.0, and 20.0 mg/kg SC) in rats fed chow alone or chow and a 32% sucrose solution. Administration of U50,488H led to analgesia. However, %MPEs did not vary directly as a function of dose. %MPEs of rats fed chow and sucrose were significantly greater than those of rats fed chow alone after injections of 10.0 and 20.0 mg/kg U50,488H. Experiment 3 compared the analgesic effect of U50,488H (5.0, 10.0, 15.0, and 20.0 mg/kg SC) in rats fed chow alone or chow and either a 0.15% saccharin solution or hydrogenated vegetable fat. Administration of U50,488H led to analgesia. However, %MPEs did not vary directly as a function of dose or as a function of diet. %MPEs of rats fed chow and fat were significantly greater than those of rats fed chow alone after injection of 5.0 mg/kg U50,488H.

PMID: 9264068 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...t_uids=10638642

1: Pharmacol Biochem Behav. 2000 Jan 1;65(1):97-104.Click here to read Links
Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats.

* Kanarek RB,
* Homoleski BA,
* Wiatr C.

Department of Psychology, Tufts University, Medford, MA 02155, USA.

Previous research has shown that rats consuming a sucrose solution and chow are more sensitive to the analgesic actions of morphine, a selective mu opioid agonist, and the anorectic actions of opioid antagonists, than rats eating only chow. However, from these data, it cannot be determined if sucrose intake only modifies the behavioral consequences of drugs that act at the mu opioid receptor, or if the sugar also alters the actions of opioid drugs that act at other opioid receptor subtypes. Thus, the present experiments examined the effects of sucrose intake on the actions of spiradoline, a selective kappa opioid agonist, on analgesia and food intake in male and female Long-Evans rats. In Experiment 1, male and female rats consumed either chow, a 32% sucrose solution and water, or only chow and water. After 3 weeks, antinociceptive responses on the tail-flick test were determined after spiradoline injections (0.0, 0.3, 1.0, and 3.0 mg/ kg, s.c.). Rats fed sucrose were more sensitive to the analgesic actions of spiradoline than rats fed only chow. In Experiment 2, drug-naive male and female rats were maintained under the same dietary conditions as in Experiment 1. Food intake was measured 1, 2, 4, and 6 h after spiradoline injections (0.0, 0.3, 1.0, and 3.0 mg/kg, s.c.). Spiradoline led to significant dose-related decreases in food intake for males and females in both dietary conditions. However, the anorectic effects of the drug were more pronounced in rats fed sucrose than in those eating only chow. These results support the hypothesis that intake of palatable foods and fluids alters the activity of the endogenous opioid system.

PMID: 10638642 [PubMed - indexed for MEDLINE]


Ok, I'm too tired to go any further with this tonight, but I think this might lead to some nice prejudiced statement about modern American lifestyles being bad in even more ways.
Frangible
QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...l=pubmed_docsum

1: Dev Med Child Neurol. 2001 Nov;43(11):755-60.Click here to read Links
Is increased D2 receptor availability associated with response to stimulant medication in ADHD.

* Ilgin N,
* Senol S,
* Gucuyener K,
* Gokcora N,
* Sener S.

Department of Nuclear Medicine, Gazi University, Ankara, Turkey. nese@med.gazi.edu.tr

The purpose of this study was to estimate striatal dopamine (D2) receptor availability in non-drug treated children with attention-deficit-hyperactivity disorder (ADHD) before and after methylphenidate therapy, and to examine correlations between severity of symptoms and response rates to stimulant medication with levels of striatal D2 receptor binding. Nine children (six males, three females; mean age 9.8 years, SD 2.3 years) with ADHD participated. All underwent iodobenzamide (123I IBZM) brain SPECT within 2 hours following intravenous injection of 123I IBZM before and 3 months after methylphenidate therapy. A semiquantitative approach was used to generate indices of specific D2 receptor binding in the basal ganglia. Specific binding ratios at baseline were higher than the previously reported specific binding values obtained in studies using young healthy adults. D2 availability reduced significantly (paired t-test,p<0.05) as a function of methylphenidate therapy in patients with ADHD in all four regions of the striatum. When the relation between therapy response and D2 availability was investigated, we observed that the higher the baseline D2 levels were, the higher the response rate was (detected as the percentage reduction of hyperactivity scores and Conners Teacher Rating Scale scores), while no such trend was observed between the initial D2 binding levels and the response in attention-deficit scores. Results indicate that in non-drug treated children with ADHD, higher D2 receptor availability is observed at baseline which is down-regulated back to reported near-normal values after methylphenidate therapy. The effect of methylphenidate on D2 receptor levels in patients with ADHD is similar to that observed in healthy adults; a down-regulation phenomenon within 0 to 30%. In addition, initially higher values of D2 availability seem to indicate better response to methylphenidate therapy in ADHD.

PMID: 11730150 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...st_uids=8793092

1: Brain Res. 1996 May 20;721(1-2):126-31.Click here to read Links
Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels.

* Welch CC,
* Kim EM,
* Grace MK,
* Billington CJ,
* Levine AS.

Department of Medicine, VA Medical Center, Minneapolis, MN 55417, USA.

Opioid involvement in regulating the intake of highly palatable diets was studied by examining the effect of feeding either a cornstarch-based diet (CHO) or a high fat diet containing sucrose (Fat/Sucrose) on hypothalamic opioid levels. Rats received either CHO ad libitum, Fat/Sucrose ad libitum, Fat/Sucrose pair-fed to the caloric intake of CHO, or Fat/Sucrose at 60% of ad libitum Fat/Sucrose intake. Animals receiving Fat/Sucrose ad libitum consumed more calories and gained more weight than animals receiving CHO (P < 0.001). Relative to CHO, ad libitum intake of Fat/Sucrose elevated proDynorphin mRNA levels in the arcuate and Dynorphin A1-17 levels in the paraventricular nucleus (PVN) (P < 0.05), but did not affect arcuate mRNA levels of proEnkephalin or proOpiomelanocortin (POMC), or PVN levels of Met-Enkephalin or beta-Endorphin. Pair-feeding the Fat/Sucrose diet to the level of intake of the CHO diet resulted in levels of proDynorphin and Dynorphin A1-17 that were similar in the two diet groups. Pair-feeding Fat/Sucrose reduced mRNA levels of proDynorpin, proEnkephalin and POMC, and Dynorphin A1-17 levels, relative to ad libitum feeding of Fat/Sucrose. Met-Enkephalin and beta-Endorphin were not affected by dietary treatment. Feeding Fat/Sucrose at 60% of ad libitum intake resulted in mRNA levels of proDynorphin, proEnkephalin and POMC, and Dynorphin A1-17 levels that were similar to those observed in CHO group. Hypothalamic Dynorphin A1-17 and proDynorphin mRNA levels are stimulated by feeding a highly palatable diet rich in fat and sucrose. The increased synthesis may be due in part to a palatability-induced overconsumption of calories. Caloric restriction of the same diet decreases mRNA levels of proDynorphin, proEnkephalin and POMC, as well as levels of Dynorphin A1-17.

PMID: 8793092 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...l=pubmed_docsum

1: Neuroreport. 1996 Jul 8;7(10):1690-4. Links
Alterations in kappa opioid receptor mRNA levels in the paraventricular nucleus of the hypothalamus by stress and sex steroids.

* Yukhananov RY,
* Handa RJ.

Department of Cell Biology, Neurobiology and Anatomy, Loyola University Medical Center, Maywood, IL 60153, USA.

In this study, the levels of kappa opioid receptor (kOR) mRNA were determined using in situ hybridization following two types of stress (i.p. injection of hypertonic saline or novelty). In addition, we examined the possibility that estrogen or androgen would modify kOR mRNA. Gonadectomized male rats treated with estrogen or dihydrotestosterone were sacrificed 45 min after spending 15 min in a novel open field, or 60 min following hypertonic saline injection. Two-way ANOVA revealed that estrogen and novelty increased the levels of kOR mRNA in the ventral zone of the medial parvocellular part of the paraventricular nucleus (PVN), but not in the lateral parvocellular part of the PVN, claustrum, nucleus accumbens or the nucleus of the lateral olfactory tract. Furthermore, novelty increased kOR mRNA in gonadectomized (GDX) and GDX rats treated with dihydrotestosterone (DHTP), but not in sham-operated or estrogen-treated animals. Taken together, these data indicate that kOR mRNA levels are under estrogenic control and up-regulated in a stressor specific fashion.

PMID: 8904783 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...t_uids=12831870

1: Neuroscience. 2003;119(4):1157-67.Click here to read Links
Evidence of increased dopamine receptor signaling in food-restricted rats.

* Carr KD,
* Tsimberg Y,
* Berman Y,
* Yamamoto N.

Department of Psychiatry, Millhauser Laboratories, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. kc16@nyu.edu

It is well established that chronic food restriction enhances sensitivity to the rewarding and motor-activating effects of abused drugs. However, neuroadaptations underlying these behavioral effects have not been characterized. The purpose of the present study was to explore the possibility that food restriction produces increased dopamine (DA) receptor function that is evident in behavior, signal transduction, and immediate early gene expression. In the first two experiments, rats received intracerebroventricular (i.c.v.) injections of the D1 DA receptor agonist SKF-82958, and the D2/3 DA receptor agonist quinpirole. Both agonists produced greater motor-activating effects in food-restricted than ad libitum-fed rats. In addition, Fos-immunostaining induced by SKF-82958 in caudate-putamen (CPu) and nucleus accumbens (Nac) was greater in food-restricted than ad libitum-fed rats, as was staining induced by quinpirole in globus pallidus and ventral pallidum. In the next two experiments, neuronal membranes prepared from CPu and Nac were exposed to SKF-82958 and quinpirole. Despite the documented involvement of cyclic AMP (cAMP) signaling in D1 DA receptor-mediated c-fos induction, stimulation of adenylyl cyclase (AC) activity by SKF-82958 in CPu and Nac did not differ between groups. Food restriction did, however, decrease AC stimulation by the direct enzyme stimulant, forskolin, but not NaF or MnCl(2), suggesting a shift in AC expression to a less catalytically efficient isoform. Finally, food restriction increased quinpirole-stimulated [(35)S]guanosine triphosphate-gammaS binding in CPu, suggesting that increased functional coupling between D2 DA receptors and G(i) may account for the augmented behavioral and pallidal c-Fos responses to quinpirole. Results of this study support the hypothesis that food restriction leads to neuroadaptations at the level of postsynaptic D1 and D2 receptor-bearing cells which, in turn, mediate augmented behavioral and transcriptional responses to DA. The signaling pathways mediating these augmented responses remain to be fully elucidated.

PMID: 12831870 [PubMed - indexed for MEDLINE]


QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...amp;dopt=DocSum

1: Bioorg Med Chem Lett. 2004 Aug 2;14(15):4083-5.Click here to read Links
Synthesis and biological evaluation of the major metabolite of atomoxetine: elucidation of a partial kappa-opioid agonist effect.

* Creighton CJ,
* Ramabadran K,
* Ciccone PE,
* Liu J,
* Orsini MJ,
* Reitz AB.

Drug Discovery, Johnson and Johnson Pharmaceutical, Research and Development, Spring House, PA 19477-0776, USA. ccreight@prdus.jnj.com

The major human metabolite of atomoxetine(Strattera) (4-hydroxyatomoxetine) was tested against a panel of receptors and enzymes, and was found to interact with the mu, delta, and kappa-opioid receptors based upon studies involving both binding and functional assays. 4-hydroxyatomoxetine was determined to be a partial agonist of the kappa-opioid receptor.

PMID: 15225731 [PubMed - indexed for MEDLINE]


imo, tying this together... (and I could be horribly wrong)

Novelty / reward / overstimulation / palatable food / euphoria all raise dynorphin levels, in an attempt by the body to regulate addiction and the pursuit of hedonism. This manifests in a reduction of pre- and postsynaptic dopamine D2 receptors in the straitum and nAC, as does treatment of ADHD with methylphenidate. Perhaps it represents the neurological correlate of the temporary nature of hedonism.

And this is why obese people have the seemingly contradictory fact of low numbers of D2 receptors. They have been downregulated by constant hyperphagia and hedonism from food, resulting in dynorphin increases leading to D2 receptor decreases. But this is not effect to completely blunt the gluttony-- and the global increase of the "self-stimulation" bar makes them seek the most rewarding, the most hedonistic things quite ironically as neuroplastic changes here have blunted the normal response to things.

In ADHD, the problem is too many D2 receptors; the excess of DATs here from genetic mutations (and whatever else) removes the DA and prevents any significant reward or hedonism from occurring in the first place. So, by the use of euphoric stimulants (which in turn increase dynorphin levels), or Strattera, whose main metabolite directly agonizes the kappa receptors as dynorphin does, result in normalization of the striatal D2 receptor densities. But, the base problem-- which led to an overpopulation of D2 receptors-- has to be corrected, or this neuroplasticity will reversed in time.

Exercise and food restriction, as shown in the above studies, decrease dynorphin levels and thus effectively lower the self-stimulation threshold... sensitizing and increasing D2 receptor densities.

The chronic treatment of kappa opioid agonists such as salvia divinorum results in not only the acute D2 reduction during treatment (which is a transient effect), but also a tolerance to the exogenous agnoist and endogenous dynorphin. As a result, the removal of reinforcement from self-stimulating behaviors results in less dynorphin getting released in the first place, and the baseline levels having less of an effect on suppressing the D2 receptors. Thus, neuroplastic "rebound" results in an unregulation of D2 receptors.

This allows the hyperphagic rat to obtain normal stimulation from regular food, resetting the threshold. But if they start eating that palpable food once again, the cycle will repeat. The same thing applies to libido- it "resets" the sensitivity to erotic stimuli.

This allows the reduction of impulsivity in ADHD by diminishing the maximum amount that things are novel by. This makes selection of non-novel things more likely. But, the person must still find a way to get reward and satisfaction from them.

So, I think that maybe, just maybe, kOR agonists can give people a chance to reset and correct poor behavioral choices and the pursuit of hedonism, reward, and materialism more quickly than behavioral changes alone, wherein they would have to force themselves to do something that does not at all appeal to them (and quit doing the shit that does appeal to them) for quite a while for this system to naturally rebalance itself. But even after the reset button is pushed, the opportunity to do it right is also the opportunity to fuck things up all over again, to start the cycle of suffering anew, and not learn from the last.

Maybe my theory is wrong, but I like it, dammit.

"Constant over stimulation numbs me
and I wouldn't have it any other way.

It's not enough, I need more.
Nothing seems to satisfy.
I don't want it, I just need it.
To feel, to breathe, to know I'm alive.
...
Something kinda sad about
the way that things have come to be.
Desensitized to everything.
What became of subtlety?

How can it mean anything to me
If I really don't feel anything at all?"
-Tool, "Stinkfist"
eclypz
Frangi, I really like your way of thinking.

So to sum this theory up - when we use dopaminergics or better yet are just plain hedonistic our body reduces or increases the number of d2 receptors to deal with the higher levels? Or does that even matter?

Something about your theory speaks to me personally and I want to try and get some kind of reset on my dopamine system, even if it's minor. I tried some salvia last night, smoked it, 5x extract. First time ever, went easy on it. Still, even though I took it slow, my whole brain turned inside out. The whole room swirled into, well, swirlies. I didn't go too deep but I didnt just graze the surface either. About ten minutes later I was just a little fuzzy headed. After that I wanted to crash out. I woke up this morning and feel somewhat less phuzzy than I usually do - a little glow about me. I dont want to take that as proof though, it could easily be expectations.

I will be trying salvia a few more nights just to see what may come of it. I will be trying to cut my dose even lower. I just don't enjoy having the room spinning like that. Perhaps I should not smoke it but put some in my cheek??

The reason I'm really interested, frangible, in this theory of yours is that time and time again I hear about people having an afterglow from using salvia, sometimes lasting a few days. Then you mentioned this d2 receptor deal and I think it makes perfect sense actually.

Jay Black
That afterglow lasted a few days with me as well, but I didn't just touch the surface when I used salvia (the 10x, a long while back now). Something about my reality being torn to shreds really changed my perspective on things...temporarily. laugh.gif
eclypz
QUOTE(Jeff @ Apr 9 2007, 06:50 AM) [snapback]396527[/snapback]
That afterglow lasted a few days with me as well, but I didn't just touch the surface when I used salvia (the 10x, a long while back now). Something about my reality being torn to shreds really changed my perspective on things...temporarily. laugh.gif


I think part of that perspective also has to do with the d2 receptor changes.

But yeah, it's crazy go nuts shit. I've just never had a real high tolerance for hallucinogens. My unconscious mind has for some reason decided that they are dangerous, so I get really uncomfortable with the whole experience. My ego must be interfering...

Jay Black
QUOTE(eclypz @ Apr 9 2007, 11:01 AM) [snapback]396531[/snapback]
I think part of that perspective also has to do with the d2 receptor changes.


Makes sense...

QUOTE
But yeah, it's crazy go nuts shit. I've just never had a real high tolerance for hallucinogens. My unconscious mind has for some reason decided that they are dangerous, so I get really uncomfortable with the whole experience. My ego must be interfering...


Many are uncomfortable with it. I wouldn't say it was the most pleasant experience for me either though.

Darksanity
To me, Salvia 20x just felt like NO "laughing gas"... as I tried it, I laughed my ass off for about 30 secs, then for the next 2 mins weird body sensations (sensation of gravity fucked up), but that was all. But as I remind myself, on LSD, I laughed my ass off for HOURS... Salvia, thus, being a 30sec LSD-like experience. I didn't feel any after-glow on salvia, probably because of the whole bunch of cannabis smoked afterwards.

I know Inositol has some effects on d2 receptor.
QUOTE(PubMed)
A large body of evidence suggests that the neuropathology of obsessive-compulsive disorder (OCD) lies in the complex neurotransmitter network of the cortico-striatal-thalamo-cortical (CSTC) circuit, where dopamine (DA), serotonin (5HT), glutamate (Glu), and gamma-amino butyric acid (GABA) dysfunction have been implicated in the disorder. Chronic inositol has been found to be effective in specific disorders that respond to selective serotonin reuptake inhibitors (SSRIs), including OCD, panic, and depression. This selective mechanism of action is obscure. Since nigro-striatal DA tracts are subject to 5HT(2) heteroreceptor regulation, one possible mechanism of inositol in OCD may involve its effects on inositol-dependent receptors, especially the 5HT(2) receptor, and a resulting effect on DA pathways in the striatum. In order to investigate this possible interaction, we exposed guinea pigs to oral inositol (1.2 g/kg) for 12 weeks. Subsequently, effects on locomotor behavior (LB) and stereotype behavior (SB), together with possible changes to striatal 5HT(2) and D(2) receptor function, were determined. In addition, the effects of chronic inositol on dexamphetamine (DEX)-induced motor behavior were evaluated. Acute DEX (3 mg/kg, ip) induced a significant increase in both SB and LB, while chronic inositol alone did not modify LA or SB. The behavioral response to DEX was also not modified by chronic inositol pretreatment. However, chronic inositol induced a significant increase in striatal D(2) receptor density (B(max)) with a slight, albeit insignificant, increase in 5HT(2) receptor density. This suggests that D(2) receptor upregulation may play an important role in the behavioral effects of inositol although the role of the 5HT(2) receptor in this response is questionable.

But is an increase in striatal d2 receptor density what we looking for (to relieve ADD)?
eclypz
QUOTE(Darksanity @ Apr 9 2007, 11:42 AM) [snapback]396580[/snapback]
To me, Salvia 20x just felt like NO "laughing gas"... as I tried it, I laughed my ass off for about 30 secs, then for the next 2 mins weird body sensations (sensation of gravity fucked up), but that was all. But as I remind myself, on LSD, I laughed my ass off for HOURS... Salvia, thus, being a 30sec LSD-like experience. I didn't feel any after-glow on salvia, probably because of the whole bunch of cannabis smoked afterwards.

I know Inositol has some effects on d2 receptor.

But is an increase in striatal d2 receptor density what we looking for (to relieve ADD)?


Finally the inositol d2 study surfaces (I was looking for that).

But YEAH-what he asked, is dopamine receptor density something we want to increase? Doesn't the body make more dopamine receptors when it feels it's being overstimulated or is it the other way around?
Frangible
According to the studies I posted above, too many straital D2 receptors are linked to ADHD, and stimulant treatment decreases them. My interpretation of that is other problems with ADHD (too little dopamine, too many DATs, poor executive and goal completion behavior, etc) lead to upregulation/sensitization of them from lack of use, and that increasing their numbers may correspond with aggravated hyperactivity/impulsivity symptoms..
Sanction
QUOTE(eclypz @ Apr 9 2007, 01:34 PM) [snapback]396591[/snapback]
is dopamine receptor density something we want to increase?
Good question.

Consider that an overactive PAM (prefrontal-amygdala-medial dorsal thalamic) circuit is related to depression symptoms.
The PAM circuit is inhibited by the ASPM (amygdala-striatal-pallidal-medial dorsal thalamic) circuit. An underactive ASPM disinhibits PAM, which is not fun. You need a balance of DA, 5HT, glutaminergic receptors to keep these circuits operating normally.

Also, overactivity of the prefrontal cortex and the caudate nucleus loop is related to OCD and attentional disregulation. Attention and distractibility are modulated by orbital cortex, striatum and thalamic centers. To oversimplify, dopamine is inhibitory.

Dopaminergic inputs to the striatum can inhibit it. Since the striatum inhibits thalamic output, excess dopaminergic activity in the striatal circuits disinhibit the thalamus, which then allows too much information to flood the cortex. This is one theory of schizophrenia.
(Abarbanel's classic paper -- see figure 5c)
To sum up: heck, I don't know.
ATB
I dont think I know either.
Sanction
QUOTE(Frangible @ Apr 8 2007, 12:39 PM) [snapback]396412[/snapback]
imo, tying this together... (and I could be horribly wrong)

Novelty / reward / overstimulation / palatable food / euphoria all raise dynorphin levels ...


Click to view attachment

Whoa. Bottom-line this for me willya? So how do I orgasm faster?
eclypz
QUOTE(Sanction @ Apr 9 2007, 01:33 PM) [snapback]396595[/snapback]
Good question.

Consider that an overactive PAM (prefrontal-amygdala-medial dorsal thalamic) circuit is related to depression symptoms.
The PAM circuit is inhibited by the ASPM (amygdala-striatal-pallidal-medial dorsal thalamic) circuit. An underactive ASPM disinhibits PAM, which is not fun. You need a balance of DA, 5HT, glutaminergic receptors to keep these circuits operating normally.

Also, overactivity of the prefrontal cortex and the caudate nucleus loop is related to OCD and attentional disregulation. Attention and distractibility are modulated by orbital cortex, striatum and thalamic centers. To oversimplify, dopamine is inhibitory.

Dopaminergic inputs to the striatum can inhibit it. Since the striatum inhibits thalamic output, excess dopaminergic activity in the striatal circuits disinhibit the thalamus, which then allows too much information to flood the cortex. This is one theory of schizophrenia.
(Abarbanel's classic paper -- see figure 5c)
To sum up: heck, I don't know.


so is the original question too simplified?

If I do too much coke all the time what does my brain do to counteract the overstimulation of dopaminergic pathways? Does it hide receptors or does it make new ones to try and keep a balance?

Let's say hypothetically that I've done too much ritalin over the past few years and my dopamine system is fried. Would increasing dopamine receptor density help or harm the problem? Would taking salvia, which blocks dopamine receptors, which would in turn let dopamine receptors go back to normal to try and fix the low dopamine, help at all?
Frangible
QUOTE(Sanction @ Apr 9 2007, 03:46 PM) [snapback]396599[/snapback]
Click to view attachment

Whoa. Bottom-line this for me willya? So how do I orgasm faster?


Use Salvia for 3-4 days in a row, perhaps. At least the data looks fairly promising for rat studies there! So if you catch yourself mounting a female rat, it worked. (if nothing else, salvia in low doses is a pretty potent libido stimulant)

QUOTE
If I do too much coke all the time what does my brain do to counteract the overstimulation of dopaminergic pathways? Does it hide receptors or does it make new ones to try and keep a balance?


Too much DA -> Dynorphin -> Kappa receptor agonism -> D2 receptor population decrease
Too little DA -> Less dynorphin baseline -> D2 receptor upregulation / sensitization** (yeah, the data's pretty shaky on that one wink.gif But we know diet/exercise do this, and hedonism does the opposite...)

QUOTE
Let's say hypothetically that I've done too much ritalin over the past few years and my dopamine system is fried. Would increasing dopamine receptor density help or harm the problem? Would taking salvia, which blocks dopamine receptors, which would in turn let dopamine receptors go back to normal to try and fix the low dopamine, help at all?


Human studies have shown that kappa opioid agonists decrease stimulant craving and lessen withdrawal. This has been reported many times with salvia anecdotally, and I can confirm this through personal experience.

Free full text: http://www.aapsj.org/view.asp?art=aapsj070361
Frangible
QUOTE(Sanction @ Apr 9 2007, 03:33 PM) [snapback]396595[/snapback]
Good question.

Consider that an overactive PAM (prefrontal-amygdala-medial dorsal thalamic) circuit is related to depression symptoms.
The PAM circuit is inhibited by the ASPM (amygdala-striatal-pallidal-medial dorsal thalamic) circuit. An underactive ASPM disinhibits PAM, which is not fun. You need a balance of DA, 5HT, glutaminergic receptors to keep these circuits operating normally.

Also, overactivity of the prefrontal cortex and the caudate nucleus loop is related to OCD and attentional disregulation. Attention and distractibility are modulated by orbital cortex, striatum and thalamic centers. To oversimplify, dopamine is inhibitory.

Dopaminergic inputs to the striatum can inhibit it. Since the striatum inhibits thalamic output, excess dopaminergic activity in the striatal circuits disinhibit the thalamus, which then allows too much information to flood the cortex. This is one theory of schizophrenia.
(Abarbanel's classic paper -- see figure 5c)
To sum up: heck, I don't know.


It is indeed very complex, and the location of the D2 receptor and whether it's pre- or postsynaptic controls its function, which is of course in the larger context of that particular circuit or region in the brain.

Which begs the question, "So isn't talking about D2 receptors globally oversimplifying things?" Well, you can blame the kappa opioid system for that one-- it has global effects and hits both pre- and postsynaptic receptors.
eclypz
This is awesome stuff, and a good read there on the page about stimulant abuse and salvinorin. Frangible I want to make a little clone of you and keep him in my pocket for when I need to learn something else.


I must admit that over a period of a few years now I've had off and on access to a number of stimulants(mostly ritalin). I haven't gone on binges that lasted several days or anything like you see in meth addicts but I can definitely tell my adventures with ritalin have left me rather anhedonic lately and I've been wondering if there might be something I can do about it. Going out and socializing feels like work lately and even going out to get smashed makes me feel only ill, instead of euphoric and jolly as it used to be.

I was a bit frightened last night with taking too much salvia so I only took one hit. I felt the whole trip start to happen but then it left too quickly. Tonight I will suck it up and go further and report on the mood shifts...

Darksanity
I have also slightly abused stimulants in my youth (well I'm still young but anyway... a few years ago). Dirty speed pills with whatever they put in it (mostly methamphetamine) and ecstasy. It probably did damage and still have some impact. I'm now on dexedrine thought (sometimes methylphenidate), for my ADD, but I try the best to keep the dose the lowest and the least often.

For me going out and socializing isn't very hard since I have the same friends since a few years, and cannabis is very friendly!!

But I wish I could "regenerate" my probably damaged dopaminergic system. Seroquel seems promising for this, but unavailability and possible risks (type II diabetes...) makes me away from it. On the other side, salvia is readily avalaible, cheap, and has very little risks!

Would it be better to take oral salvia much like a supplement or smoke extracts? Many ppl eat salvia instead of smoking to allow less intense longer trips. Has anyone tried it?
eclypz
QUOTE(Darksanity @ Apr 10 2007, 02:58 PM) [snapback]396672[/snapback]
I have also slightly abused stimulants in my youth (well I'm still young but anyway... a few years ago). Dirty speed pills with whatever they put in it (mostly methamphetamine) and ecstasy. It probably did damage and still have some impact. I'm now on dexedrine thought (sometimes methylphenidate), for my ADD, but I try the best to keep the dose the lowest and the least often.

For me going out and socializing isn't very hard since I have the same friends since a few years, and cannabis is very friendly!!

But I wish I could "regenerate" my probably damaged dopaminergic system. Seroquel seems promising for this, but unavailability and possible risks (type II diabetes...) makes me away from it. On the other side, salvia is readily avalaible, cheap, and has very little risks!

Would it be better to take oral salvia much like a supplement or smoke extracts? Many ppl eat salvia instead of smoking to allow less intense longer trips. Has anyone tried it?


I found a really neat recipe to make blotter paper out of salvia leaf. You can use the stuff orally but it takes a lot and it takes a bit of chewing(unless you use a tincture or blotter paper). I will look into getting some leaf myself to try out...

I have this funny feeling that says the longer you can extend the experience the longer the afterglow will work.

There are quite a few people who use this stuff purely for it's antidepressant activity it seems after googling for a while...
Frangible
I would think the "afterglow" would help with burnout / anhedonia etc. As far as oral forms, I've only used the oral tincture (alcohol-based; I lose at attempting to smoke things) but it really, really fucking burns. Not pleasant (well, at least until the salvia kicks in). OTOH, at least you don't have the risk of falling into ego death and dropping something burning onto something flammable.

Personally I'd love to see salvorin A in a transdermal carrier.

I don't know if inhalation vs. oral would have more therapeutic potential. I think from the duration of the "afterglow" described, it doesn't seem so much related to the length of effects, so at least part of it is independent.

Oh, and I once did use salvia as an antidepressant-- I was really emo'ing out. A pretty massive dose reversed the depressive state, with about zero other effects.

Strattera/atomoxetine might be another option-- apparently its major metabolite is a kappa agonist. (I used it for a month, it basically made me narcoleptic)
eclypz
I didn't like statera. I thought it was cool the first time I took it, like a super charged cup of coffee, but then it just fell flat...

Here's the instructions on how to make blotter paper which sound like just about the best way to take salvia.

http://www.totse.com/en/drugs/psychedelics...lott170441.html
Frangible
QUOTE(eclypz @ Apr 11 2007, 09:08 AM) [snapback]396794[/snapback]
I didn't like statera. I thought it was cool the first time I took it, like a super charged cup of coffee, but then it just fell flat...

Here's the instructions on how to make blotter paper which sound like just about the best way to take salvia.

http://www.totse.com/en/drugs/psychedelics...lott170441.html


Hmm, interesting if it works... I dunno if it'd be absorbed well enough without the alcohol in the mouth.
eclypz
QUOTE(Frangible @ Apr 11 2007, 08:41 AM) [snapback]396811[/snapback]
Hmm, interesting if it works... I dunno if it'd be absorbed well enough without the alcohol in the mouth.


I'll let you know, as I'm always down with trying something like this. I may prerinse with mouthwash like some do.
Jay Black
I've used salvia sublingual before, which works very well (also not as chaotic), but you must go with the regular leaves...not the extracts. And use a ton of it laugh.gif
Frangible
Another random kappa opioid factoid:

QUOTE
http://www.ncbi.nlm.nih.gov/entrez/query.f...l=pubmed_docsum

... Basal A4 and T release remained unaffected by kappa agonist treatment, but the cells cultured in the presence of LH generally increased both androgen production in response to these opioids. Basal secretion of E2 was also suppressed by kappa agonists...
Frangible
I just took a (low) dose. After perceiving the effects with and without meditating, my impression is that salvia sort of turns up the volume in terms of perceptible effects on things that are always there, but difficult to perceive because of the amount of other crap going on in our brains. I still think if I was better at meditation and took the drug enough times, I could get to the point where I could recreate the effects it has by will alone, just in noticing how it consistently shifts my perception and feeling of consciousness in the same direction, to the same point, every time.
Darksanity
humans are being bombarded CONSTANTLY by all outside energy, and our brains do a fantastic job at filtering what we receive into something we can relate to, removing all the weird shit. Psychedelics decrease some of the filtering

I'm ordering some right away!!
AdelV
where can i buy bulk salvia?
eclypz
QUOTE(AdelV @ Jul 13 2007, 04:56 PM) [snapback]412297[/snapback]
where can i buy bulk salvia?


I have finally gotten to the point where I can handle the salvia trip and I have to say the afterglow is the best. Four or five days of being completely in a state of contentment. It's quite nice.

One of the things that's helped a lot is to have something very pleasing to listen to whilst diving. If you don't it seems like any external noise turns into a living being that distracts and sometimes even brings me down. Also, the internal dialogue can take off and interupt the experience. A good 10-15 minutes of ambient music really does the trick to pull you into a blissful and meditative state.
Darksanity
I've smoked some 20x extract a few weeks ago and never touched again. I think I could try a smaller dose. I also have some 20x "tincture". I wonder what would be a good dose to not get the full "ego-death"...
geigertube
QUOTE(Frangible @ Apr 10 2007, 06:14 PM) [snapback]396702[/snapback]
Oh, and I once did use salvia as an antidepressant-- I was really emo'ing out. A pretty massive dose reversed the depressive state, with about zero other effects.



Was the dose one, or several? And oral or smoked? And, (last question) can you be more specific about what the "massive dose" was?
Darksanity
Yeah since for me, a single puff of 20x extract got me into full-blown "ego-death"... Really freaky... But amazing... (I could easily write a whole book describing this 5 minute experience)

What is weird is that when coming back to reality you feel extremely confused and really baaaaad (absolute dysphoria). Once reality becomes clearer the dysphoria dissapears and a feeling of "afterglow", incredible antidepressant effect, takes place.
Sal Collaziano
No kidding.. I figured the 20x was going to be strong so I took a real light hit (water pipe). I was in another world for 5 minutes. And when I got back, I didn't know who's house I was in.

QUOTE(Darksanity @ Jul 19 2007, 04:22 PM) [snapback]413273[/snapback]
Yeah since for me, a single puff of 20x extract got me into full-blown "ego-death"... Really freaky... But amazing... (I could easily write a whole book describing this 5 minute experience)

What is weird is that when coming back to reality you feel extremely confused and really baaaaad (absolute dysphoria). Once reality becomes clearer the dysphoria dissapears and a feeling of "afterglow", incredible antidepressant effect, takes place.

eclypz
QUOTE(Darksanity @ Jul 19 2007, 04:22 PM) [snapback]413273[/snapback]
Yeah since for me, a single puff of 20x extract got me into full-blown "ego-death"... Really freaky... But amazing... (I could easily write a whole book describing this 5 minute experience)

What is weird is that when coming back to reality you feel extremely confused and really baaaaad (absolute dysphoria). Once reality becomes clearer the dysphoria dissapears and a feeling of "afterglow", incredible antidepressant effect, takes place.


for about a week after no less. I feel great and troubles seem to mean so little.

The great part is that it's not because it's artificially raising levels of stuff that will crash after it's over. It's reseting things which feels much more productive in the long run.

Music is essential to the experience. Any external noise like fans I found have a haunting effect on the trip.
Darksanity
QUOTE(eclypz @ Jul 20 2007, 11:50 AM) [snapback]413402[/snapback]
for about a week after no less. I feel great and troubles seem to mean so little.

The great part is that it's not because it's artificially raising levels of stuff that will crash after it's over. It's reseting things which feels much more productive in the long run.

Music is essential to the experience. Any external noise like fans I found have a haunting effect on the trip.

I found any sensory stimulation (light, music, etc.) to be disturbing while into the trip. Anything making me go back to reality was really disturbing (like re-learning everything from the beginning but way too fast).

Anyway I won't go into details since as I said, I could easily write a book about my single experience with it.
Gahan
QUOTE(Darksanity @ Jul 20 2007, 01:12 PM) [snapback]413519[/snapback]
I found any sensory stimulation (light, music, etc.) to be disturbing while into the trip. Anything making me go back to reality was really disturbing (like re-learning everything from the beginning but way too fast).

Anyway I won't go into details since as I said, I could easily write a book about my single experience with it.


I like some music, but one time I took a huge rip of 20x extract from a water bong while a Chili Peppers song was playing. Then fucking Linkin' Park started their shit on my radio, and I swear that snapped me back to reality just long enough to change to another station.

I go\et really, really happy after hitting Salvia and am very resolute and focused. It is my favorite psychedelic by far. I don't mind the ego death really...
methodice
Bump for more experiences and Darksanitys new book smile.gif I would like to read more about your experience actually.

I'm sure it would be a bit more enlightening than the reports from totse. I just found this site...It's quite funny in a way, their forum was down so I couldn't go further. Here were a few front pages things I found.

http://www.totse.com/en/drugs/otc/badtripoffbena.html - Complex issues addressed complete with references!

http://www.totse.com/en/drugs/otc/.html - Apparently we have been using it the wrong way!

http://www.totse.com/en/drugs/otc/.html - Love the saying "baked out of my gourd"

http://www.totse.com/en/drugs/otc/dontmakethesam.html

"i looked through my house for a bottle of robotussin i had found on 2/3 empty it didnt really work so a few times later i tried taking whole bottles of the shit. it was a pretty good high i later found out it was the oppisite of speed it slows down your system.after i knew alot about it and tried it a couple times i decided to go 'robotrippin' with a friend we bought 2 bottle of dm robotussin i drank a bottle and a half and he drank about half a bottle. wow i felt good until my brother came home and saw my friend was acting strange he was usually very outgoing but now his system had slowed down a little so my friend told my brother what had happened and he took matters into his own hands and told my mom. then my mom was furious she offered us this stuff to through up i didnt take it but my friend did which made him feel horrible. i couldnt find a drug that worked for me yet so far my brother had ruined dxm whic i liked the search was on i even tried taking 6 benadryls in school once which led to delirium. then it hit me wtf was i wasting all my time on OTC (over the counter drugs) so i tried the obvious solution WEED"

Tkardde, can we organise an M&M article from one of these writers please smile.gif
Pound4Pound
QUOTE(eclypz @ Jul 20 2007, 11:50 AM) [snapback]413402[/snapback]
Music is essential to the experience. Any external noise like fans I found have a haunting effect on the trip.

What type of music would you recommend? During my last experience, a ticking clock had an effect on my trip. It set the beat for some chanting, rhythmic "song" that all the little oompa-loompa like people were marching to. Crazy stuff.
Gahan
QUOTE(Pound4Pound @ Sep 17 2007, 07:49 AM) [snapback]423504[/snapback]
What type of music would you recommend? During my last experience, a ticking clock had an effect on my trip. It set the beat for some chanting, rhythmic "song" that all the little oompa-loompa like people were marching to. Crazy stuff.


Comptine D'Un Autre: L'Apres Midid -Yann Tiersen ('Amelie' sound track)

http://www.youtube.com/watch?v=4Z2ljWwIaHs

Don't mind the silly video...
keninishna
I remember reading somewhere chronic salvia use makes you suicidal... Ill have to look up a refrence.
oyster
QUOTE(keninishna @ Sep 18 2007, 01:16 PM) [snapback]423760[/snapback]
I remember reading somewhere chronic salvia use makes you suicidal... Ill have to look up a refrence.


searching government sites or sites with the word "parent" would probably be the best way to find that...
D-termine
http://www.albinoblacksheep.com/flash/flashback

I think this could be similar to a salvia trip, although I've never been that deep personally. It reminds me of dxm trips Ive had though
Tiabin
Hey guys,
I was really surprised to run across this thread. I registered on this forum years ago and was doing reading on salvia for specifically the same reasons as mentioned on this thread.
I found myself reading through it and going... "Wow. People like me. People who love to learn, and love science."

Kudos and all that.

My experience with salvia has been the same as much on here... Overall I find I enjoy smoking the LEAVES the best (it's more mild and less scary... less overwhelming) which can be bought pretty affordably off of ebay. It's a good clearheaded buzz but tends to be anti-addictive... which means you have to really activate that masochisitic bodybuilding hit-the-iron mechanism to reap the benefits of it.... but the afterbuzz is very pleasant.
methodice
And where have you been the past 4 years Mr?

"It's a good clearheaded buzz but tends to be anti-addictive... which means you have to really activate that masochisitic bodybuilding hit-the-iron mechanism to reap the benefits of it"

What do you mean?
Tiabin
QUOTE(methodice @ Oct 1 2007, 10:45 AM) [snapback]426226[/snapback]
And where have you been the past 4 years Mr?

"It's a good clearheaded buzz but tends to be anti-addictive... which means you have to really activate that masochisitic bodybuilding hit-the-iron mechanism to reap the benefits of it"

What do you mean?

Hahah... Me and my five posts have you beat on the registration date by two months. ;-)

Basically, I used to be really into bodybuilding. I kept lifting up but slacked, lost my passion for it, and god knows didn't feel like chatting online about it... I never knew about this forum before though, and neuroscience is my current passion. (Actually I've recently been getting hardcore back into lifting -- but mostly because of the effects it has on the brain.)

In other words, kappa opioid agonists are literally used to treat coke addiction. It reduces dopamine levels in a certain addiction-related area of the brain and because of this tends to make you not want to smoke it again. That's the reason for salvia's initial dysphoria (pre-the afterglow).
eclypz
Yeah, I'd probably be using this stuff a lot more often to reset my mind. After about six small experiments I've gotten to the point where the trip just kinda sucks and the discomfort that follows is a drag. I might hit it up again soon but for now I might look into getting the leaves and chewing them or something so that it's not as "hit over the head" strong.
luv2increase
I smoke salvia a few times back in H.S., probably around 2001. I definitely noticed the messed up gravity effects. I was like a 5 minute (at the most) weird and weak acid trip. Overall, I liked it but didn't care to use it all the time. It was just an experimental thing. I always like acid but hated shrooms with a passion! lol



I will probably be starting focalin here within a week.

Do you think salvia would be good to use every other day to help off-set the long-term negative dopaminergic effects from long-term methylphenidate use?

I also have an addicting personality but only want to use the medication as prescribed so I can actually finish my degree. Would the salvia help me not to want to crush up a pill and snort it like I did with ritalin years back?
Darksanity
QUOTE(luv2increase @ Oct 4 2007, 04:07 PM) [snapback]426880[/snapback]
Would the salvia help me not to want to crush up a pill and snort it like I did with ritalin years back?

I don't think Salvia would change anything about that but... Have you ever wondered about taking Concerta?
graatch
QUOTE
Would the salvia help me not to want to crush up a pill and snort it like I did with ritalin years back?


Yeah, I think so, if one "reason" you want to do that is boredom/anergic depression. Taking the ritalin as prescribed will help to not do that too.
oyster
Also note that the evidence with inositol & ADHD are mixed or negative. So maybe depression and ADHD have different conditions here, or it could depend on the subtypes of these. But inositol could have multiple mechanisms.

Its also worth noting that reverse tolerance is commonly noted with salvia (for psychedelic effects).

can we say, to simplify, that mu signal = DO THIS AGAIN
and the kappa signal = get rid of the eurphoric aspects, without affecting the reinforcement/desire part (ie, it says 'this activity is good, and its expected/status quo from now on)

from the cocaine addiction studies, it seems like pretreatment with KOR agonists 'unmakes' the reward path that was created by following the euphoria.

and thus has antidepressant effects by encouraging the smoker to find new reward paths instead of the stunted ones exhibited in ahedonia?

Some possibly relevant studies i can't figure out how to relate.

QUOTE
Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens.
Chefer VI, Shippenberg TS.

Integrative Neuroscience Section, Behavioral Neuroscience Branch, DHHS/NIH/NIDA/IRP/BNRB/INS, 5500 Nathan Shock Drive, Baltimore, MD 21224, USA. vchefer@intra.nida.nih.gov

Quantitative and conventional microdialysis were used to investigate the effects of constitutive deletion of the prodynorphin gene on basal dopamine (DA) dynamics in the nucleus accumbens (NAc) and the responsiveness of DA neurons to an acute cocaine challenge. Saline- and cocaine-evoked locomotor activity were also assessed. Quantitative microdialysis revealed that basal extracellular DA levels were decreased, while the DA extraction fraction, an indirect measure of DA uptake, was unchanged in dynorphin (DYN) knockout (KO) mice. The ability of cocaine to increase NAc DA levels was reduced in KO. Similarly, cocaine-evoked locomotor activity was decreased in KO. The selective kappa opioid receptor agonist U-69593 decreased NAc dialysate DA levels in wildtype mice and this effect was enhanced in KO. Administration of the selective kappa opioid receptor (KOPr) antagonist nor-binaltorphimine to KO mice attenuated the decrease in cocaine-induced DA levels. However, it was ineffective in altering the decreased locomotor response to cocaine. These studies demonstrate that constitutive deletion of prodynorphin is associated with a reduction of extracellular NAc DA levels and a decreased responsiveness to acute cocaine. Data regarding the effects of U-69593 and nor-binaltorphimine in KO suggest that the kappa opioid receptor is up-regulated as a consequence of prodynorphin gene deletion and that this adaptation underlies the decrease in basal DA dynamics and cocaine-evoked DA levels observed in DYN KO mice. These findings suggest that the phenotype of DYN KO mice is not solely due to loss of endogenous opioid peptide but also reflects developmental compensations that occur at the level of the opioid receptor.


(DA is higher in the NA during depression)

QUOTE
c-Fos antisense oligodeoxynucleotide offsets behavioral nociceptive responses and both up-regulations of c-Fos protein and dynorphin a (1-8) in dorsal horn: a study using the formalin test in rats.
Zhang Y, Qiao JT, Dafny N.

Department of Neurobiology, Shanxi Medical University, Taiyuan, PR China.

The formalin test was used to elicit acute and chronic pain in rats, and antisense oligodeoxynucleotide (AS-ODN) was used as a tool to modulate the expression of nociceptive behavioral and neurochemical responses. AS-ODN complementary to c-Fos mRNA was administered intrathecally (i.t.) 4 h before formalin injection in the experimental group. Normal saline or reverse AS-ODN was pre-administered i.t. at the same time in two control groups (saline and reverse AS-ODN). The results showed that the acute phase of nociceptive behavior showed no change by AS-ODN administration, whereas the tonic phase of nociceptive licking and biting behavior was significantly suppressed by AS-ODN as compared with the saline or the reverse AS-ODN group, respectively (p < .05 and p < .01). At the same time, both Fos-like immunoreactive (FLI) neurons and density of dynorphin-like immunoreactivities (DLI) were decreased significantly (p < .05 and p < .01) in the AS-ODN group as compared with that in two control groups. The results indicate that the long-lasting nociceptive responses elicited by sustained noxious inputs are based on the up-regulation of c-Fos gene expression, which in turn induces the upregulation of Dyn A production. It is proposed that intensified Dyn A production in the dorsal horn may be pivotal for the appearance of chronic pain.


There are theories of depression that it is a chronic state of pain, thus the reduced sensitivity to normal pains in the depressed.

This indicates KOR has feedback from vassopressin & oxytocin release. - interesting especially since the effect of extremely high dose salvia is no memory of the trip, and large doses have trips that are hard to remember. Oxytocin could be related to the 'heat' sensation many people experience after taking a hit of salvia, although i don't know how oxytocin affects temperature regualtion, just that it is involved somehow. I wonder if there is a rebound effect?

QUOTE
We investigated the influence of endogenous kappa -opioids on the activity of supraoptic neurons in vivo. Administration of the kappa -antagonist nor-binaltorphimine (200 µg/kg, i.v.), increased the activity of phasic (vasopressin), but not continuously active (oxytocin), supraoptic neurons by increasing burst duration (by 69 ± 24%) and decreasing the interburst interval (by 19 ± 11%). Similarly, retrodialysis of nor-binaltorphimine onto the supraoptic nucleus increased the burst duration (119 ± 57% increase) of vasopressin cells but did not alter the firing rate of oxytocin cells (4 ± 8% decrease). Thus, an endogenous kappa -agonist modulates vasopressin cell activity by an action within the supraoptic nucleus. To eliminate kappa -agonist actions within the supraoptic nucleus, we infused the kappa -agonist U50,488H (2.5 µg/hr at 0.5 µg/hr) into one supraoptic nucleus over 5 d to locally downregulate kappa -receptor function. Such infusions reduced the spontaneous activity of vasopressin but not oxytocin cells and reduced the proportion of cells displaying spontaneous phasic activity from 26% in vehicle-infused nuclei to 3% in U50,488H-infused nuclei; this treatment also prevented acute inhibition of both vasopressin and oxytocin cells by U50,488H (1000 µg/kg, i.v.), confirming functional kappa -receptor downregulation. In U50,488H-infused supraoptic nuclei, vasopressin cell firing rate was increased by nor-binaltorphimine (100 and 200 µg/kg, i.v.) but not to beyond that found in vehicle-treated nuclei, indicating that these cells were not U50,488H-dependent. Thus, normally functioning kappa -opioid mechanisms on vasopressin cells are essential for the expression of phasic firing.
...Vasopressin (Watson et al., 1982) and oxytocin (Levin and Sawchenko, 1993; Eriksson et al., 1996) cells also synthesize the kappa -opioid peptide dynorphin; indeed the highest levels of expression seen in the CNS are in vasopressin cells (Molineaux et al., 1982). Dynorphin is present in the dendrites of vasopressin cells (Watson et al., 1982) and is copackaged with vasopressin in the same neurosecretory granules in the axon terminals (Whitnall et al., 1983), and is thus co-secreted with vasopressin. Exogenous dynorphin attenuates exocytosis from neurosecretory terminals (Rusin et al., 1997), but although co-released dynorphin clearly restrains oxytocin release, it does not influence vasopressin secretion from isolated neurohypophysial preparations (Bicknell et al., 1985; Bondy et al., 1988). Hence, the physiological significance of dynorphin expression in vasopressin cells is currently unknown.
http://www.jneurosci.org/cgi/content/full/18/22/9480


Also, if comparing dynorphin activity to KOR activity, keep in mind dynorphins have other effects, whereas i think salvinorin A is highly selective for the KOR.

QUOTE
Mechanisms of induction of persistent nociception by dynorphin.
Laughlin TM, Larson AA, Wilcox GL.

Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.

The opioid peptide dynorphin has been demonstrated to be both nociceptive and antinociceptive. This article will review the potential mechanisms through which dynorphin contributes to spinally mediated nociception. Specifically, we will examine the interaction of dynorphin with multiple sites on the NMDA receptor complex. Dynorphin-induced opioid activity is generally inhibitory, with a tendency to impede nociceptive signals and serve in a neuroprotective capacity. In contrast, dynorphin's interaction with multiple sites on the NMDA receptor complex produces excitatory responses resulting in nociceptive and even toxic effects. Thus, it is hypothesized that dynorphin has both physiological and pathological roles in acute and chronic pain states.

PMID: 11561057 [PubMed - indexed for MEDLINE]

QUOTE
In summary, the effects of dynorphin are not consistent with those of mu agonists and, on the basis of limited human data, also appear to differ from those of kappa agonists.

http://jpet.aspetjournals.org/cgi/content/full/281/3/1154


plus reference to "dynorphin A" as DA confuse me to no end.

I'm still trying to see if there is some connection between the relationship between KOR and novelty, and the psychedelic effects of salvia.

Also interesting strattera is used for ADHD, but was ineffective for depression.
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.